Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli–induced hemolytic uremic syndrome
- 19 May 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 117 (20), 5503-5513
- https://doi.org/10.1182/blood-2010-09-309161
Abstract
Hemolytic uremic syndrome (HUS) is commonly associated with Shiga toxin (Stx)–producing Escherichia coli O157:H7 infection. This study examined patient samples for complement activation on leukocyte-platelet complexes and microparticles, as well as donor samples for Stx and lipopolysaccharide (O157LPS)–induced complement activation on platelet-leukocyte complexes and microparticles. Results, analyzed by flow cytometry, showed that whole blood from a child with HUS had surface-bound C3 on 30% of platelet-monocyte complexes compared with 14% after recovery and 12% in pediatric controls. Plasma samples from 12 HUS patients were analyzed for the presence of microparticles derived from platelets, monocytes, and neutrophils. Acute-phase samples exhibited high levels of platelet microparticles and, to a lesser extent, monocyte microparticles, both bearing C3 and C9. Levels decreased significantly at recovery. Stx or O157LPS incubated with donor whole blood increased the population of platelet-monocyte and platelet-neutrophil complexes with surface-bound C3 and C9, an effect enhanced by costimulation with Stx and O157LPS. Both Stx and O157LPS induced the release of C3- and C9-bearing microparticles from platelets and monocytes. Released microparticles were phagocytosed by neutrophils. The presence of complement on platelet-leukocyte complexes and microparticles derived from these cells suggests a role in the inflammatory and thrombogenic events that occur during HUS.This publication has 46 references indexed in Scilit:
- Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunctionPediatric Nephrology, 2010
- Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic SyndromeClinical Journal of the American Society of Nephrology, 2009
- Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic SyndromePLOS ONE, 2009
- ROLE OF THE ALTERNATIVE PATHWAY IN THE EARLY COMPLEMENT ACTIVATION FOLLOWING MAJOR TRAUMAShock, 2007
- Platelet activation leads to activation and propagation of the complement systemThe Journal of Experimental Medicine, 2005
- Phagocytosis and Killing of Bacteria by Professional Phagocytes and Dendritic CellsClinical and Vaccine Immunology, 2002
- Direct binding of C1q to apoptotic cells and cell blebs induces complement activationEuropean Journal of Immunology, 2002
- ComplementNew England Journal of Medicine, 2001
- Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomesEuropean Journal of Biochemistry, 1988
- Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.The Journal of Experimental Medicine, 1979